Genomic profiling of Submucosal-Invasive gastric cancer by Array-Based comparative genomic hybridization

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Kuroda, Akiko ^a   Tsukamoto, Yoshiyuki ^a   Nguyen, Lam Tung ^a   Noguchi, Tsuyoshi ^a   Takeuchi, Ichiro ^b   Uchida, Masahiro ^a   Uchida, Tomohisa ^a   Hijiya, Naoki ^a   Nakada, Chisato ^a   Okimoto, Tadayoshi ^a   Kodama, Masaaki ^a   Murakami, Kazunari ^a   Matsuura, Keiko ^a   Seto, Masao ^c   Ito, Hisao ^d   Fujioka, Toshio ^a   Moriyama, Masatsugu ^a  

^a OITA UNIVERSITY   (Japan)

^b NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CHROMOSOME; CHROMOSOME 11Q13; CHROMOSOME 11Q14; CHROMOSOME 11Q22; CHROMOSOME 14Q32; CHROMOSOME 17Q21; CLINICAL ARTICLE; CLONAL VARIATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; EARLY CANCER; ERBB2 GENE; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENETIC HETEROGENEITY; GENOMICS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; STOMACH CANCER; STOMACH MUCOSA; SUBMUCOSA; SUBMUCOSAL INVASIVE GASTRIC CANCER; BIOLOGICAL MODEL; GENE DELETION; GENETICS; HUMAN GENOME; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR;

CORTACTIN; CTTN PROTEIN, HUMAN; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN;

AGED; AGED, 80 AND OVER; COMPARATIVE GENOMIC HYBRIDIZATION; CORTACTIN; DNA COPY NUMBER VARIATIONS; FEMALE; GASTRIC MUCOSA; GENETIC HETEROGENEITY; GENOME, HUMAN; GENOMICS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SEQUENCE DELETION; STOMACH NEOPLASMS;

EID: 79960638907     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022313     Document Type: Article

References (49)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. Haruta H, Hosoya Y, Sakuma K, Shibusawa H, Satoh K, et al. (2008) Clinicopathological study of lymph-node metastasis in 1,389 patients with early gastric cancer: assessment of indications for endoscopic resection. J Dig Dis 9: 213-218.
3. Kwee RM, Kwee TC, (2008) Predicting lymph node status in early gastric cancer. Gastric Cancer 11: 134-148.
4. Vogelstein B, Kinzler KW, (2004) Cancer genes and the pathways they control. Nat Med 10: 789-799.
5. Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G, (1999) Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25: 195-204.
6. Uchida M, Tsukamoto Y, Uchida T, Ishikawa Y, Nagai T, et al. (2010) Genomic profiling of gastric carcinoma in situ and adenomas by array-based comparative genomic hybridization. J Pathol 221: 96-105.
7. Merlo LM, Pepper JW, Reid BJ, Maley CC, (2006) Cancer as an evolutionary and ecological process. Nat Rev Cancer 6: 924-935.
8. Heng HH, Bremer SW, Stevens JB, Ye KJ, Liu G, et al. (2009) Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective. J Cell Physiol 220: 538-547.
9. Heng HH, Stevens JB, Bremer SW, Ye KJ, Liu G, et al. (2010) The evolutionary mechanism of cancer. J Cell Biochem 109: 1072-1084.
10. Polyak K, (2008) Is breast tumor progression really linear? Clin Cancer Res 14: 339-341.
11. Davies JJ, Wilson IM, Lam WL, (2005) Array CGH technologies and their applications to cancer genomes. Chromosome Res 13: 237-248.
12. Harada K, Nishizaki T, Ozaki S, Kubota H, Ito H, et al. (1998) Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas. Cancer Res 58: 4694-4700.
13. Harada T, Okita K, Shiraishi K, Kusano N, Kondoh S, et al. (2002) Interglandular cytogenetic heterogeneity detected by comparative genomic hybridization in pancreatic cancer. Cancer Res 62: 835-839.
14. Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, et al. (2009) Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 15: 559-565.
15. Torres L, Ribeiro FR, Pandis N, Andersen JA, Heim S, et al. (2007) Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases. Breast Cancer Res Treat 102: 143-155.
16. Gorringe KL, Boussioutas A, Bowtell DD, (2005) Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization. Genes Chromosomes Cancer 42: 247-259.
17. Nakayama T, Ling ZQ, Mukaisho K, Hattori T, Sugihara H, (2010) Lineage analysis of early and advanced tubular adenocarcinomas of the stomach: continuous or discontinuous? BMC Cancer 10: 311.
18. Peng DF, Sugihara H, Mukaisho K, Ling ZQ, Hattori T, (2004) Genetic lineage of poorly differentiated gastric carcinoma with a tubular component analysed by comparative genomic hybridization. J Pathol 203: 884-895.
19. Takada H, Imoto I, Tsuda H, Sonoda I, Ichikura T, et al. (2005) Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization. Cancer Sci 96: 100-110.
20. Tomioka N, Morita K, Kobayashi N, Tada M, Itoh T, et al. (2010) Array comparative genomic hybridization analysis revealed four genomic prognostic biomarkers for primary gastric cancers. Cancer Genet Cytogenet 201: 6-14.
21. Tsukamoto Y, Uchida T, Karnan S, Noguchi T, Nguyen LT, et al. (2008) Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J Pathol 216: 471-482.
22. Vauhkonen H, Vauhkonen M, Sajantila A, Sipponen P, Knuutila S, (2006) DNA copy number aberrations in intestinal-type gastric cancer revealed by array-based comparative genomic hybridization. Cancer Genet Cytogenet 167: 150-154.
23. Vauhkonen H, Vauhkonen M, Sipponen P, Knuutila S, (2007) Oligonucleotide array comparative genomic hybridization refines the structure of 8p23.1, 17q12 and 20q13.2 amplifications in gastric carcinomas. Cytogenet Genome Res 119: 39-45.
24. Weiss MM, Kuipers EJ, Postma C, Snijders AM, Pinkel D, et al. (2004) Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cell Oncol 26: 307-317.
25. Yang S, Jeung HC, Jeong HJ, Choi YH, Kim JE, et al. (2007) Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer. Genomics 89: 451-459.
26. Bargmann CI, Hung MC, Weinberg RA, (1986) The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319: 226-230.
27. Di Fiore PP, Pierce JH, Kraus MH, Segatto O, King CR, et al. (1987) erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237: 178-182.
28. Semba K, Kamata N, Toyoshima K, Yamamoto T, (1985) A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci U S A 82: 6497-6501.
29. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, et al. (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532.
30. Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, et al. (2000) Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 60: 2002-2006.
31. Maley CC, Galipeau PC, Finley JC, Wongsurawat VJ, Li X, et al. (2006) Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet 38: 468-473.
32. Khalique L, Ayhan A, Weale ME, Jacobs IJ, Ramus SJ, et al. (2007) Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours. J Pathol 211: 286-295.
33. Cooke SL, Ng CK, Melnyk N, Garcia MJ, Hardcastle T, et al. Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma. Oncogene 29: 4905-4913.
34. Cooke SL, Temple J, Macarthur S, Zahra MA, Tan LT, et al. Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer. Br J Cancer 104: 361-368.
35. Aubele M, Mattis A, Zitzelsberger H, Walch A, Kremer M, et al. (1999) Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet Cytogenet 110: 94-102.
36. Mora J, Cheung NK, Gerald WL, (2001) Genetic heterogeneity and clonal evolution in neuroblastoma. Br J Cancer 85: 182-189.
37. Yachida S, Jones S, Bozic I, Antal T, Leary R, et al. (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467: 1114-1117.
38. Sayagues JM, Abad Mdel M, Melchor HB, Gutierrez ML, Gonzalez-Gonzalez M, et al. (2010) Intratumoural cytogenetic heterogeneity of sporadic colorectal carcinomas suggests several pathways to liver metastasis. J Pathol 221: 308-319.
39. Cooke SL, Ng CK, Melnyk N, Garcia MJ, Hardcastle T, et al. (2010) Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma. Oncogene 29: 4905-4913.
40. Heidenblad M, Lindgren D, Veltman JA, Jonson T, Mahlamaki EH, et al. (2005) Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications. Oncogene 24: 1794-1801.
41. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, et al. (2002) Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62: 6240-6245.
42. Jarvinen AK, Autio R, Haapa-Paananen S, Wolf M, Saarela M, et al. (2006) Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses. Oncogene 25: 6997-7008.
43. Yoshimoto T, Matsuura K, Karnan S, Tagawa H, Nakada C, et al. (2007) High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. J Pathol 213: 392-401.
44. Barros-Silva JD, Leitao D, Afonso L, Vieira J, Dinis-Ribeiro M, et al. (2009) Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. Br J Cancer 100: 487-493.
45. Falck VG, Gullick WJ, (1989) c-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study. J Pathol 159: 107-111.
46. Kim MA, Jung EJ, Lee HS, Lee HE, Jeon YK, et al. (2007) Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction. Hum Pathol 38: 1386-1393.
47. Park DI, Yun JW, Park JH, Oh SJ, Kim HJ, et al. (2006) HER-2/neu amplification is an independent prognostic factor in gastric cancer. Dig Dis Sci 51: 1371-1379.
48. Park JB, Rhim JS, Park SC, Kimm SW, Kraus MH, (1989) Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas. Cancer Res 49: 6605-6609.
49. Takehana T, Kunitomo K, Kono K, Kitahara F, Iizuka H, et al. (2002) Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay. Int J Cancer 98: 833-837.